INSIGHTS ON DRUG DEVELOPMENT
-
mRNA LNPs Drive Safe, Effective Repeat Dosing In Disease Models
Repeat dosing may be essential for long-term mRNA applications. Explore safety, immune-response, and efficacy findings from multiple LNP administrations, including a nine-dose evaluation over six months.
-
Cell Culture Media Filtration: Evaluating Cell Culture Performance
Cell culture performance remained consistent across PES and PVDF filters, even under worst-case filtration conditions. Discover a practical framework for evaluating membrane impact on CHO cell growth.
-
Turning A "Brick Dust" Compound Into A Clinically Viable Oral Formulation
Advanced wet milling and particle stabilization improve solubility, enhance bioavailability, and support scalable manufacturing for complex oral drug development programs.
-
Advancing Drug Safety And Improving R&D Productivity With The Liver-Chip S1
Explore how the Emulate Liver-Chip S1 revolutionizes predictive toxicology by mimicking human liver biology, achieving superior sensitivity and specificity.
-
Transforming Research Through Lab Automation7/6/2026
Self-driving labs bring automation and AI together to transform research. Learn about how continuous experimentation and real-time learning unlock faster insights and more efficient paths to innovation.
-
Building Confidence In Combination Product Development11/12/2026
Early compatibility testing with realistic placebo models helps mitigate formulation risks, ensuring accurate dosing, predictable injection times, and long-term stability.
-
Ask Us Anything: Päivi Tolstoy On The Future Of API Manufacturing7/23/2026
Päivi Tolstoy, Manager of Process Development at Cambrex Karlskoga, on why sustainability is the trend to watch in API manufacturing — and why the real question is how few steps it takes to build a complex molecule.
-
Pioneers And Visionaries Of Nucleic Acid And Nanoparticle-Based Therapeutics12/12/2024
Explore the future of nucleic acid and nanoparticle-based therapeutics, including mRNA, CRISPR, and gene editing, as experts discuss innovative solutions for complex health challenges.
-
How To Reduce Batch Loss In Biopharma Production12/12/2025
Batch failures in biopharma remain costly despite improvements. Learn the leading causes in downstream purification and how supplier expertise can help reduce risk and protect production.
DRUG DEVELOPMENT SOLUTIONS
-
A single site pairs a portfolio of specialty reagents with custom manufacturing, from a condensation reagent used in amide bond formation to biocatalysis, hydrogenation, and more at scale.
-
Curia was the first CRO to provide contract medicinal chemistry services to the pharmaceutical industry.
-
Unexpected downtime can drastically impact your organization’s ability to service customers and hinder innovation. With Waters FlexCHOICE: mySystem Coverage*, you can safeguard against lost productivity and unexpected downtime and spend more time on what matters most – your customers and your research.
-
Our integrated capabilities and vast knowledge encompasses pre-formulation sciences, formulation development, device evaluation, clinical trial manufacturing and the clinical assessment of a variety of inhaled formats for nasal and pulmonary delivery.
-
Learn more about a closed, automated isolation and bead removal system for cell therapy manufacturing used to streamline and expedite your cell therapy development.